tiprankstipranks
89bio receives EMA PRIME status for Pegozafermin
PremiumThe Fly89bio receives EMA PRIME status for Pegozafermin
23d ago
89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosis
PremiumPress Releases
89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosis
23d ago
Insider Trading: RA Capital Buys Stock Worth $15M in LENZ Therapeutics
PremiumMarket News
Insider Trading: RA Capital Buys Stock Worth $15M in LENZ Therapeutics
23d ago
89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
1M ago
Insider Trading: Director Boosts Stake in 89bio (NASDAQ:ETNB) Stock 
PremiumMarket News
Insider Trading: Director Boosts Stake in 89bio (NASDAQ:ETNB) Stock 
1M ago
89bio price target raised to $37 from $29 at Evercore ISI
PremiumThe Fly
89bio price target raised to $37 from $29 at Evercore ISI
1M ago
89bio price target lowered to $31 from $32 at H.C. Wainwright
PremiumThe Fly89bio price target lowered to $31 from $32 at H.C. Wainwright
2M ago
89bio reports Q4 EPS (50c), consensus (49c)
PremiumThe Fly
89bio reports Q4 EPS (50c), consensus (49c)
2M ago
89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
PremiumPress Releases
89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100